SOLIGENIX, INC. Accounts Payable
SOLIGENIX, INC. (SNGX) had Accounts Payable of $1.41 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-07
- 2026-06-30: Accounts Payable, Current $1.41M.
- 2026-03-31: Accounts Payable, Current $828.66K.
- 2025-12-31: Accounts Payable, Current $1.12M.
- 2025-09-30: Accounts Payable, Current $1.21M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.41M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $828.66K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.12M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $1.21M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $649.96K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $599.69K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $667.90K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $891.23K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $1.70M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $1.44M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $1.11M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $1.46M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.47M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $2.77M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $3.87M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $4.16M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $4.14M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $4.52M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $2.93M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.91M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.48M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $1.34M 10-Q · filed 2021-05-18 | |
| 2020-12-31 | $2.13M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $2.44M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $2.52M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $2.87M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $2.74M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $2.26M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.45M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $1.58M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $2.13M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $1.71M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.69M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $1.75M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $1.75M 10-K · filed 2019-03-26 | |
| 2017-09-30 | $1.48M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $1.61M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $1.35M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $1.71M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $3.12M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $4.18M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $4.63M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $2.87M 10-K · filed 2017-03-27 | $4.38M 10-K · filed 2016-03-24 |
| 2015-09-30 | $4.35M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $2.64M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $2.54M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $3.00M 10-K · filed 2016-03-24 | |
| 2014-09-30 | $3.06M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.97M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $1.55M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $1.52M 10-K · filed 2015-03-25 | |
| 2013-09-30 | $1.21M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $1.36M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $1.65M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $1.12M 10-K · filed 2014-03-26 | |
| 2012-09-30 | $1.02M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $1.22M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $1.23M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $1.30M 10-K · filed 2013-02-26 | |
| 2011-09-30 | $1.37M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.37M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $1.67M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |